mechanism of action glp-1 agonist What is and Its Receptor Agonists? GLP-1 & GIP Agonists |

CKD = Chronic Kidney Disease

These findings highlight the importance of maintaining continuous GLP-1 treatment to sustain cardiovascular benefits and indicate that strategies to reduce treatment discontinuity should be developed to maximize the cardioprotective effects of GLP-1s

Its like concierge weight loss care from home

Moreover, the results of cardiovascular outcome trials in persons with T2D given GLP-1RA demonstrating reduced stroke, myocardial infarction, and cardiovascular death 35 along with the emerging evidence demonstrating positive effects of GLP-1RAs 36,37 on kidney outcomes adds further impetus that these drugs have pleiotropic benefits

Will people eventually be prescribed GLP-1s to reduce their Alzheimers risk